ClinicalTrials.Veeva

Menu

Ocular Surface Disease and IOP Monitoring With Travoprost Without Conservatives

D

Democritus University of Thrace

Status

Completed

Conditions

Glaucoma
Ocular Surface Disease
Glaucoma; Drugs

Treatments

Diagnostic Test: Schirmer Test
Diagnostic Test: Intraocular pressure (IOP)
Diagnostic Test: Visual Fields and OCT RNFL
Diagnostic Test: Conjuctival Hyperemia
Diagnostic Test: Tear Break-up Time (TBUT)

Study type

Observational

Funder types

Other

Identifiers

NCT05319470
ES3/Th11/03-02-2022

Details and patient eligibility

About

Primary objective of this study is to study the efficacy of travoprost without preservatives in the treatment of glaucoma patients and to monitor the ocular surface.

Full description

This is a prospective study including patients visiting the outpatient glaucoma clinic of the University General Hospital of Alexandroupolis for their standard evaluation. Study population is already under treatment with a travoprost preparation without preservatives. They will be fully informed about the procedure and the purpose of the study and a written consent will be obtained. For every patient included in the study intraocular pressure will be measured using a Goldman applanation tonometer, according to the standard way of practice at our clinic. Also, Tear Break-Up-Time (BUT), conjunctival hyperemia grading and Schirmer testing will be used to assess the ocular surface state. Visual field tests and OCT RNFL measurements will also be obtained. The above measurements will be repeated 6 months after the initial examination.

Enrollment

25 patients

Sex

All

Ages

35 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with glaucoma treated with travoprost without preservatives.

Exclusion criteria

  • Co-administration of another anti-glaucoma preparation with or without preservatives, Sjogren's syndrome, poor eyelid occlusion of any etiology.

Trial design

25 participants in 1 patient group

Study Group
Description:
100 patients with diagnosed glaucoma receiving travoprost without preservatives
Treatment:
Diagnostic Test: Conjuctival Hyperemia
Diagnostic Test: Schirmer Test
Diagnostic Test: Intraocular pressure (IOP)
Diagnostic Test: Visual Fields and OCT RNFL
Diagnostic Test: Tear Break-up Time (TBUT)

Trial contacts and locations

1

Loading...

Central trial contact

Ntonti Panagiota, MD,MSc; Georgios Labiris, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems